therapies

Siemens to acquire robotic surgery systems maker Corindus for $1.1 billion

Siemens Healthineers is set to acquire what the company describes as a “forerunner in robotic-assisted vascular interventions”, Corindus Vascular Robotics.

The engineering giant says the acquisition of Corindus is a “strategically significant extension of Siemens Healthineers’ Advanced Therapies business”.

Siemens Healthineers will combine its cardiovascular and neuro-interventional therapy systems with Corindus’ technology, driving procedure optimization for image-based minimally invasive therapies. [Read more…] about Siemens to acquire robotic surgery systems maker Corindus for $1.1 billion

Aston University wins funding to develop robotic stem cell factory

Aston University is playing a critical role in a €6 million EU project working to develop a robotic stem cell factory, which will reduce the cost of manufacturing adult stem cells and open up the opportunity to produce new therapies for a range of conditions.

The Autostem consortium, coordinated by NUI Galway in Ireland, has received funding through the European Commission’s Horizon 2020 programme to address the current challenges in manufacturing stem cells.

Dr Qasim Rafiq, academic lead for the project at Aston University and Lecturer in Bioprocess Engineering, explains: “Stem cell therapies have the potential to treat currently unmet patient needs and provide therapies for conditions such as diabetes, heart disease and Parkinson’s. [Read more…] about Aston University wins funding to develop robotic stem cell factory